Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Skin diseases like alopecia areata and psoriasis may be linked to blood clotting issues and heart problems.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tridax procumbens has medicinal properties.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Targeting blood vessels may help treat skin diseases.

Five FDA-approved drugs may help block COVID-19 virus entry.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Five FDA-approved drugs may help block COVID-19 virus entry.

New vitamin D3 forms need the vitamin D receptor to reduce fibrosis in human cells.

Sodium citrate causes less pain than acid citrate dextrose-A in PRP therapy.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.